| La'shon Thedford, LPN | |
|
62 Northbound Gratiot Ave, Mount Clemens, MI 48043-2310 | |
| (586) 468-8983 | |
| Not Available |
| Full Name | La'shon Thedford |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 62 Northbound Gratiot Ave, Mount Clemens, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750787164 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 4703104399 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| La'shon Thedford, LPN 62 Northbound Gratiot Ave, Mount Clemens, MI 48043-2310 Ph: () - | La'shon Thedford, LPN 62 Northbound Gratiot Ave, Mount Clemens, MI 48043-2310 Ph: (586) 468-8983 |
News Archive
"Grand Challenges Canada just announced grants of $100,000 for 102 imaginative new ideas to tackle health problems in resource-poor countries," Inter Press Service reports, noting, "Of these, 59 grants went to researchers in 13 low- and middle-income nations worldwide."
Neuroscientists at Johns Hopkins have discovered that mice lacking an enzyme that contributes to Alzheimer disease exhibit a number of schizophrenia-like behaviors. The finding raises the possibility that this enzyme may participate in the development of schizophrenia and related psychiatric disorders and therefore may provide a new target for developing therapies.
American children are likely to face serious health consequences from new and existing industrial chemicals in the environment, argue a group of researchers in a report in this month's premier open-access global health journal PLoS Medicine.
Scientists are reporting a possible explanation for the bone loss that may occur following long-term use of a medicine widely used to treat epilepsy, bipolar disorder, and other conditions. The drug, valproate, appears to reduce the formation of two key proteins important for bone strength, they said. Their study, which offers a solution to a long-standing mystery, appears in ACS' monthly Journal of Proteome Research.
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.
› Verified 6 days ago